HighTower Advisors’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,930
| Closed | -$504K | – | 3056 |
|
|
2020
Q3 | $504K | Buy |
5,930
+59
| +1% | +$2.98K | ﹤0.01% | 1565 |
|
|
2020
Q2 | $208K | Sell |
5,871
-35,336
| -86% | -$1.03M | ﹤0.01% | 1972 |
|
|
2020
Q1 | $554K | Sell |
41,207
-522
| -1% | -$8.78K | ﹤0.01% | 1292 |
|
|
2019
Q4 | $881K | Buy |
41,729
+1,343
| +3% | +$23.7K | 0.01% | 1203 |
|
|
2019
Q3 | $538K | Sell |
40,386
-1,662
| -4% | -$24.4K | ﹤0.01% | 1472 |
|
|
2019
Q2 | $583K | Sell |
42,048
-782
| -2% | -$11.8K | ﹤0.01% | 1443 |
|
|
2019
Q1 | $823K | Sell |
42,830
-3,900
| -8% | -$62.9K | 0.01% | 1225 |
|
|
2018
Q4 | $667K | Buy |
46,730
+307
| +0.7% | +$6.09K | 0.01% | 1213 |
|
|
2018
Q3 | $964K | Buy |
46,423
+1,874
| +4% | +$44.4K | 0.01% | 1144 |
|
|
2018
Q2 | $1.05M | Sell |
44,549
-9,601
| -18% | -$193K | 0.01% | 1098 |
|
|
2018
Q1 | $790K | Buy |
54,150
+2,285
| +4% | +$37.3K | 0.01% | 1207 |
|
|
2017
Q4 | $840K | Buy |
51,865
+50
| +0.1% | +$590 | 0.01% | 1202 |
|
|
2017
Q3 | $727K | Sell |
51,815
-1,245
| -2% | -$12.4K | 0.01% | 1253 |
|
|
2017
Q2 | $469K | Sell |
53,060
-5,055
| -9% | -$35.5K | ﹤0.01% | 1395 |
|
|
2017
Q1 | $375K | Buy |
58,115
+7,050
| +14% | +$35.7K | ﹤0.01% | 1454 |
|
|
2016
Q4 | $187K | Sell |
51,065
-3,400
| -6% | -$10.1K | ﹤0.01% | 1695 |
|
|
2016
Q3 | $180K | Buy |
54,465
+600
| +1% | +$1.68K | ﹤0.01% | 1668 |
|
|
2016
Q2 | $127K | Sell |
53,865
-6,450
| -11% | -$21.6K | ﹤0.01% | 1581 |
|
|
2016
Q1 | $153K | Hold |
60,315
| – | – | ﹤0.01% | 1856 |
|
|
2015
Q4 | $184K | Buy |
60,315
+350
| +0.6% | +$977 | ﹤0.01% | 1767 |
|
|
2015
Q3 | $104K | Buy |
59,965
+9,200
| +18% | +$23.5K | ﹤0.01% | 1730 |
|
|
2015
Q2 | $206K | Buy |
+50,765
| New | +$208K | ﹤0.01% | 1347 |
|
HighTower Advisors's IMMU Position: Q4 2020 in Review
HighTower Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 5,930 shares — an estimated $504K sold.
HighTower Advisors first reported a position in IMMU in Q2 2015 and held it in 22 quarters. The position peaked at $1.05M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- HighTower Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- HighTower Advisors sold 5,930 Immunomedics Inc shares in Q4 2020, an estimated $504K.
- HighTower Advisors first reported a position in Immunomedics Inc in Q2 2015 and held it in 22 quarters.
- HighTower Advisors's Immunomedics Inc position peaked at $1.05M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on HighTower Advisors's 13F filing for Q4 2020, filed 10 Feb 2021.